In addition, myxovirus resistance B (MxB) demonstrates the ability to inhibit HIV-1 infection, but when the N-terminal sequence of MxB is replaced with either the PY (Pro-Tyr) NLS or the arginine-rich NLS, it loses its capacity to suppress HIV-1 virus production (38). Here, MX2 is linked to HIV-1 infection.